DMFs are confidential, proprietary assets that present to the FDA the formulae, processes, test methodology, and other data relevant to the manufacture of products used in the composition, packaging and processing of pharmaceuticals or biologics. Indian firms accounted for 104 out of the 251 new DMFs made in the US in April-June 2006, compared with 74 out of 213 a year ago.
Source: Business-Standard.com
